Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists.
Clark JC, Martin EM, Morán LA, Di Y, Wang X, Zuidscherwoude M, Brown HC, Kavanagh DM, Hummert J, Eble JA, Nieswandt B, Stegner D, Pollitt AY, Herten DP, Tomlinson MG, García A, Watson SP.
Clark JC, et al. Among authors: moran la.
Commun Biol. 2023 Apr 7;6(1):376. doi: 10.1038/s42003-023-04766-6.
Commun Biol. 2023.
PMID: 37029319
Free PMC article.